Abstract
The intracellular protease inhibitor, SERPINB9 (Sb9), is a regulator of the cytotoxic lymphocyte protease, granzyme B (GzmB). Although primarily involved in the destruction of compromised cells, recent evidence suggests that GzmB is also involved in lysosome-mediated death of the cytotoxic lymphocyte itself. Sb9 protects the cell from GzmB released from lysosomes into the cytosol. Here we show that reactive oxygen species (ROS) generated within cytotoxic lymphocytes by receptor stimulation are required for lyososomal permeabilization, and release of GzmB into the cytosol. Importantly, ROS also inactivate Sb9 by oxidizing a highly conserved cysteine pair (P1-P1 in rodents; P1 -P2 in other mammals) in the reactive center loop to form a vicinal disulfide bond. Replacement of the P4-P3 reactive center loop residues of the prototype serpin, SERPINA1, with the P4-P5 residues of Sb9 containing the cysteine pair is sufficient to convert SERPINA1 into a ROS-sensitive GzmB inhibitor. Conversion of the cysteine pair to serines in either human or mouse Sb9 results in a functional serpin that inhibits GzmB and resists ROS inactivation. We conclude that ROS sensitivity of Sb9 allows the threshold for GzmB-mediated suicide to be lowered, as part of a conserved post-translational homeostatic mechanism regulating lymphocyte numbers or activity. It follows for example that antioxidants may improve NK cell viability in adoptive immunotherapy applications by stabilizing Sb9.
| Original language | English |
|---|---|
| Pages (from-to) | 3626-3638 |
| Number of pages | 13 |
| Journal | Journal of Biological Chemistry |
| Volume | 291 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - 12 Feb 2016 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- immunotherapy
- lysosome
- natural killer cells (NK cells)
- protease
- reactive oxygen species (ROS)
- serpin
- T cell
- SerpinB9
- granzyme B
- lysosomal membrane permeabilization
Projects
- 1 Finished
-
Control of proteases in infectious, degenerative and cardiovascular disease
Whisstock, J. (Primary Chief Investigator (PCI)), Bird, P. (Chief Investigator (CI)), Bottomley, S. (Chief Investigator (CI)), Buckle, A. (Chief Investigator (CI)), Pike, R. (Chief Investigator (CI)) & Smith, I. (Chief Investigator (CI))
NHMRC - National Health and Medical Research Council (Australia)
1/01/08 → 31/12/12
Project: Research
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver